No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TYRA TYRA BIOSCIENCES, INC.
- 17.690
- -0.760-4.12%
Close May 22 16:00 ET
929.43MMarket Cap-10467P/E (TTM)
18.610High17.600Low69.14KVolume18.450Open18.450Pre Close1.23MTurnover0.44%Turnover RatioLossP/E (Static)52.54MShares20.67052wk High2.38P/B276.73MFloat Cap10.38052wk Low--Dividend TTM15.64MShs Float31.360Historical High--Div YieldTTM5.47%Amplitude4.930Historical Low17.856Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew rec
Express News | Tyra Biosciences Inc. : Oppenheimer Raises Target Price to $28 From $25
Tyra Biosciences Price Target Maintained With a $28.00/Share by Wedbush
Tyra Biosciences Price Target Maintained With a $28.00/Share by Wedbush
Express News | HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $23 Price Target
Express News | Tyra Biosciences Q1 2024 Adj EPS $(0.35) Beats $(0.46) Estimate
Express News | Tyra Biosciences Inc: Current Cash, Cash Equivalents and Marketable Securities on Hand as of Q1 Allow Co to Execute on Plans Through at Least 2026
Comments
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
5
Upgrades
• $Funko(FNKO.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines(LUV.US$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife(MET.US$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment(MTG.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake(SNOW.US$ : JPMorgan Upgrades to Overweigh...
• $Funko(FNKO.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines(LUV.US$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife(MET.US$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment(MTG.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake(SNOW.US$ : JPMorgan Upgrades to Overweigh...
17
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg